Clarity Medical: April Filing Confirms Stable Capital Structure and Full Public Float Compliance

Bulletin Express05-05

Clarity Medical Group Holding Limited (Clarity Medical) submitted its Monthly Return for Equity Issuer for the period ended 30 April 2026, highlighting a month of capital stability with no share issuances, cancellations or treasury-share movements.

Authorised and Issued Share Capital • Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 50.00 million. • Issued share count was unchanged at 536.33 million ordinary shares. • No treasury shares were held, issued or cancelled during the month.

Public Float Status • Management certified that the company continued to meet the Main Board’s minimum 25% public-float requirement as at 30 April 2026.

Equity Incentive Arrangements • Pre-IPO Share Option Scheme: No outstanding, granted or exercised options; no shares reserved. • Share Award Plan (approved 23 November 2022): Up to 43.97 million shares remain available for future awards; no awards were granted, vested or transferred in April.

Capital Movements Summary • Net change in issued shares: 0. • Net change in treasury shares: 0.

The April filing affirms Clarity Medical’s unchanged share capital and adherence to Hong Kong Listing Rules, providing shareholders with clarity on the company’s equity position.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment